
BIOX Stock Forecast & Price Target
BIOX Analyst Ratings
Bulls say
Bioceres Crop Solutions Corp demonstrates a positive outlook due to its established crop protection portfolio, which has shown robustness outside of Argentina, indicating strong growth potential amidst domestic challenges. The company’s management is optimistic about international opportunities, particularly for its HB4 wheat revenue anticipated in the United States, Brazil, and Australia, despite acknowledging the time required to ramp up revenues with new partnerships. Additionally, the strong performance of bio-protection products in the U.S. and Latin America, as well as the success of adjuvant sales in Brazil, provide further support for the company’s financial resilience and growth prospects.
Bears say
Bioceres Crop Solutions Corp has experienced significant revenue declines due to weaker demand for its Crop Protection and Crop Nutrition solutions in Argentina, compounded by lower contributions from HB4-related sales following a shift to a licensing-based business model. Specifically, Crop Nutrition revenues decreased by approximately 34% year-over-year, amounting to around $25 million, as pricing pressures and reduced corn acreage have impacted market performance. Additionally, revenues from Seed and Integrated products fell drastically by about 75% year-over-year to approximately $8 million, highlighting the challenges faced during the transition to a seed technology partnership.
This aggregate rating is based on analysts' research of Bioceres Crop Solutions Corp and is not a guaranteed prediction by Public.com or investment advice.
BIOX Analyst Forecast & Price Prediction
Start investing in BIOX
Order type
Buy in
Order amount
Est. shares
0 shares